DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 126 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $287,000 | -91.3% | 6,400 | -88.9% | 0.00% | -90.0% |
| Q4 2020 | $3,303,000 | +15.4% | 57,879 | +3.7% | 0.01% | 0.0% |
| Q3 2020 | $2,863,000 | -62.0% | 55,807 | -55.8% | 0.01% | -33.3% |
| Q2 2020 | $7,536,000 | +34.1% | 126,204 | -7.6% | 0.02% | +7.1% |
| Q1 2020 | $5,620,000 | +6.0% | 136,542 | -41.9% | 0.01% | +40.0% |
| Q2 2019 | $5,304,000 | +81.6% | 235,172 | +86.8% | 0.01% | -9.1% |
| Q1 2019 | $2,921,000 | +10.6% | 125,864 | 0.0% | 0.01% | -8.3% |
| Q4 2018 | $2,642,000 | -45.8% | 125,864 | 0.0% | 0.01% | -33.3% |
| Q3 2018 | $4,873,000 | +50.7% | 125,864 | +53.1% | 0.02% | +50.0% |
| Q2 2018 | $3,234,000 | – | 82,196 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $18,687,872 | 15.44% |
| Redmile Group, LLC | 5,582,105 | $86,243,522 | 3.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,218,638 | $80,627,957 | 1.80% |
| BRAIDWELL LP | 3,241,351 | $50,078,873 | 1.65% |
| Parkman Healthcare Partners LLC | 491,772 | $7,597,877 | 1.65% |
| Sunesis Advisors, LLC | 96,299 | $1,487,820 | 1.07% |
| ARMISTICE CAPITAL, LLC | 4,100,000 | $63,345,000 | 0.91% |
| Deep Track Capital, LP | 1,363,201 | $21,061,455 | 0.86% |
| AlphaCentric Advisors LLC | 72,500 | $1,120,125 | 0.77% |
| Ikarian Capital, LLC | 174,510 | $2,696,179 | 0.61% |